Data-Driven Decision Making

TeamUp launches its AI Business Advisor, a tool set to transform fitness studio management by turning raw business data into strategic, actionable insights.

The popular transit app now uses AI to learn your travel habits, offering custom routes and tradeoff summaries. But what is the cost of this convenience?

A new patented drug, budiodarone, aims to treat atrial fibrillation in heart failure patients, a group with few safe options. Is this the future of care?

TPT's President Sylvia Strobel wins a top national award, highlighting a new model for public media that blends innovation with deep community roots.

ClassLink's new Insights platform aims to prove the ROI of digital tools by linking usage data to test results, a potential game-changer for school budgets.

With record 2025 revenue and a dominant hold on the gene therapy market, Cryoport's strategic investments pave a path toward profitability.

As probation and parole agencies buckle under pressure, Securus Monitoring showcases an AI-driven ecosystem aimed at easing burdens and aiding rehabilitation.

A new report from the nation's largest eye care provider boasts stellar results. We dig into the data, the industry trends, and what it means for patients.

PathAI's PathAssist Derm receives FDA Breakthrough designation, promising to enhance accuracy and speed in diagnosing the most common cancer in the U.S.

An Atlanta clinic combines lasers, biologics, and AI to challenge traditional joint surgery. Can a new marketing push make it a national alternative?

A new partnership leverages advanced AI and metabolomics to find novel drug targets for rare metabolic disorders, offering new hope for millions worldwide.

As retail crime costs Canadians billions, the RCC awards its top loss prevention leaders who are fighting back with innovation and new technology.

The trans-pacific merger between US BioTek and Australia's NutriPATH creates a major new force in functional medicine, promising expanded global access.

At MWC, Lifecycle Software unveils NEXUS® IQ, an AI platform promising to cut telco churn by 40% and transform raw customer data into profit.

Popular weight-loss drugs are linked to fewer ER visits for chronic migraine, a new study finds, sparking hope and questions about a new treatment frontier.

The industry's largest independent support provider modernizes its brand to reflect a strategic shift into a full-lifecycle ecosystem for aircraft owners.

As the spring market heats up, learn how strategic landscaping and simple maintenance can yield over 200% ROI and make your home irresistible to buyers.

French giant Efor deepens its North American footprint, acquiring CQV specialist DynamixE to target the complex cell and gene therapy manufacturing market.

The infant nutrition giant is entering Canada's booming organic market, betting on brand trust to compete in an increasingly crowded and conscious space.

Fresh off a major clinical trial victory, Alumis Inc. heads to a key investor conference. What's next for its promising pipeline and soaring stock?